Clinical Trial Update: Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial update of neural stem cell–based virotherapy for newly diagnosed malignant glioma; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Astrocytoma Grade Iii
• Astrocytoma Grade Iv
• Brain Cancer
• Glioblastoma Multiforme
• Glioma

Drugs mentioned

• neural stem cell–based virotherapy

Snippet

Sponsor: Northwestern University | Conditions: Glioma, Anaplastic Astrocytoma | Phase 1 | Status: COMPLETED | Results posted: 2023-01-20